The HPB/Stomach Cancer team at University Surgical Associates and University Specialty Surgery Associates is a group of specialists who have extensive experience in treating patients with complex malignancies. Because we focus on specific cancers, we understand the many subtleties and nuances of the disease, which aids our team in providing patients with the most up-to-date and advanced treatment options.
Every patient in our program receives a multidisciplinary treatment plan. Committed to clinical excellence, our team includes surgical oncologists, medical oncologists, radiation oncologists, interventional radiologists, hepatologists, Gastrointestinal specialists, transplant surgeons, geneticists, and specialized diagnostic radiologists and pathologists.
These experts meet weekly to review and discuss each patient and ensure their treatment plan is specifically tailored to the their individualized needs. We provide the full range of standard and innovative therapies.
Most patients with these cancers require several special types of treatments. The team works together to ensure all patient care is fully coordinated.
For patients with early stage cancer, surgical removal of the tumor offers the best chance for a cure. Surgeons at University Specialty Surgery Associates and University Surgical Associates provide the full range of standard and advanced procedures, including minimally invasive/robotic surgeries for eligible patients.
Radiation is an important element of treatment for many patients. Radiation oncologists work closely with other specialists to ensure a coordinated care path.
Newer advances in chemotherapy agents and treatment sequencing are contributing to improved outcomes for cancer patients. Chemotherapy is an essential part of cancer therapy.
Minimally Invasive Interventional Radiology (IR) procedures can destroy liver tumors, deliver drugs and radiation directly to the site of the cancer, and set the stage for other treatments. Our IR team offers the full range of these treatments.
Patients with early liver cancer may be eligible for liver transplantation. We work closely with UCSF main campus’ transplant team to coordinate transplantation, if indicated.
Clinical trials are studies of new treatments and new ways of using existing treatments. Our cancer team is actively involved in national research programs offering patients access to new clinical treatment protocols.
Many patients with these cancers may also have other co-morbidities. Our cancer specialists include physicians who specialize in managing such patients. Our Palliative care program provides support and services for patients with complex symptoms.
Second Opinion Program
When you are diagnosed with any serious disease, it makes sense to get a second opinion. University Specialty Surgery Associates and University Surgical Associates’ cancer program gives patients fast access to physicians who specialize in complex malignancies. Our experienced team will evaluate your medical history and confirm your diagnosis and talk to you about your options and make sure you are receiving the most effective care for your condition.